Host genotype and time dependent antigen presentation of viral peptides: predictions from theory

The rate of progression of HIV infected individuals to AIDS is known to vary with the genotype of the host, and is linked to their allele of human leukocyte antigen (HLA) proteins, which present protein degradation products at the cell surface to circulating T-cells. HLA alleles are associated with Gag-specific T-cell responses that are protective against progression of the disease. While Pol is the most conserved HIV sequence, its association with immune control is not as strong. To gain a more thorough quantitative understanding of the factors that contribute to immunodominance, we have constructed a model of the recognition of HIV infection by the MHC class I pathway. Our model predicts surface presentation of HIV peptides over time, demonstrates the importance of viral protein kinetics, and provides evidence of the importance of Gag peptides in the long-term control of HIV infection. Furthermore, short-term dynamics are also predicted, with simulation of virion-derived peptides suggesting that efficient processing of Gag can lead to a 50% probability of presentation within 3 hours post-infection, as observed experimentally. In conjunction with epitope prediction algorithms, this modelling approach could be used to refine experimental targets for potential T-cell vaccines, both for HIV and other viruses.

[1]  John Yin,et al.  Effects of RNA splicing and post-transcriptional regulation on HIV-1 growth: a quantitative and integrated perspective. , 2005, Systems biology.

[2]  Anthony W. Purcell,et al.  Kinetics of Antigen Expression and Epitope Presentation during Virus Infection , 2013, PLoS pathogens.

[3]  Catherine A. Sugar,et al.  Early HLA-B*57-Restricted CD8+ T Lymphocyte Responses Predict HIV-1 Disease Progression , 2012, Journal of Virology.

[4]  D. Heckerman,et al.  Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.

[5]  Philip J. R. Goulder,et al.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication , 2008, Nature Reviews Immunology.

[6]  Z. Szallasi,et al.  Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes , 2016, Nature Biotechnology.

[7]  R. J. Cohen,et al.  Promiscuous binding of extracellular peptides to cell surface class I MHC protein , 2012, Proceedings of the National Academy of Sciences.

[8]  E. Rosenberg,et al.  Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles , 2007, Journal of Virology.

[9]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[10]  R. Siliciano,et al.  Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor , 2008, Journal of Virology.

[11]  J. Yin,et al.  Quantitative intracellular kinetics of HIV type 1. , 1999, AIDS research and human retroviruses.

[12]  Bin Li,et al.  HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition , 2008, Journal of Virology.

[13]  R. Young,et al.  Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.

[14]  Tin Wee Tan,et al.  Structural bioinformatics Prediction of HLA-DQ 3 . 2 b Ligands : evidence of multiple registers in class II binding peptides , 2006 .

[15]  A. Kamali,et al.  Human Leukocyte Antigen Variants B*44 and B*57 Are Consistently Favorable during Two Distinct Phases of Primary HIV-1 Infection in Sub-Saharan Africans with Several Viral Subtypes , 2011, Journal of Virology.

[16]  Eric J. Arts,et al.  Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.

[17]  O. Lund,et al.  The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage , 2005, Immunogenetics.

[18]  Martin A. Nowak,et al.  Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA , 1999, The Journal of experimental medicine.

[19]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[20]  U. Şahin,et al.  Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.

[21]  Pamela Zave,et al.  Design of an Adaptive, Parallel Finite-Element System , 1979, TOMS.

[22]  M. Essex,et al.  Reduced Viral Replication Capacity of Human Immunodeficiency Virus Type 1 Subtype C Caused by Cytotoxic-T-Lymphocyte Escape Mutations in HLA-B57 Epitopes of Capsid Protein , 2008, Journal of Virology.

[23]  Luca Cardelli,et al.  A Peptide Filtering Relation Quantifies MHC Class I Peptide Optimization , 2011, PLoS Comput. Biol..

[24]  J. Prado,et al.  Early Antigen Presentation of Protective HIV-1 KF11Gag and KK10Gag Epitopes from Incoming Viral Particles Facilitates Rapid Recognition of Infected Cells by Specific CD8+ T Cells , 2012, Journal of Virology.

[25]  O. Lund,et al.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy? , 2012, Expert review of vaccines.

[26]  D. Hamby A review of techniques for parameter sensitivity analysis of environmental models , 1994, Environmental monitoring and assessment.

[27]  Philip J. R. Goulder,et al.  Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.

[28]  Charles R. M. Bangham,et al.  T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules , 2009, PLoS Comput. Biol..

[29]  R. Phillips,et al.  Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. , 1996, AIDS research and human retroviruses.

[30]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[31]  Edward C. Holmes,et al.  Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.

[32]  Morten Nielsen,et al.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery , 2010, Immunology.

[33]  R. Serban,et al.  CVODES: The Sensitivity-Enabled ODE Solver in SUNDIALS , 2005 .

[34]  Robert F. Siliciano,et al.  Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations , 2006, The Journal of experimental medicine.

[35]  Hans Wolf,et al.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.

[36]  Morten Nielsen,et al.  Peptide‐MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity , 2012, European journal of immunology.

[37]  Todd M. Allen,et al.  Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells , 2008, PLoS medicine.

[38]  B. Walker,et al.  Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication. , 1999, Journal of immunology.

[39]  R. Kaul,et al.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. , 2001, The Journal of clinical investigation.

[40]  V. Veloso,et al.  Association of the HLA-B*52 allele with non-progression to AIDS in Brazilian HIV-1-infected individuals , 2014, Genes and Immunity.

[41]  Bjoern Peters,et al.  The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design , 2017, Front. Immunol..

[42]  Stefan Tenzer,et al.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. , 2009, Nature immunology.

[43]  Johnson Mak,et al.  Maintenance of the Gag/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral Infectivity , 2001, Journal of Virology.

[44]  J. Strominger,et al.  Assembly and dissociation of human leukocyte antigen (HLA)-A2 studied by real-time fluorescence resonance energy transfer. , 2000, Biochemistry.

[45]  M. Nebuloni,et al.  Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load , 2013, Front. Immunol..

[46]  D. Katzenstein,et al.  Novel and Promiscuous CTL Epitopes in Conserved Regions of Gag Targeted by Individuals with Early Subtype C HIV Type 1 Infection from Southern Africa1 , 2004, The Journal of Immunology.

[47]  Yen-Liang Chen,et al.  The Proteolytic Cleavage of Human Immunodeficiency Virus Type 1 Nef Does Not Correlate with Its Ability To Stimulate Virion Infectivity , 1998, Journal of Virology.

[48]  Hans D. Mittelmann,et al.  Prediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model , 2010, BMC Bioinformatics.

[49]  C. Wachihi,et al.  HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort. , 2013, Tissue antigens.

[50]  A. Goldberg,et al.  26S proteasomes and immunoproteasomes produce mainly N‐extended versions of an antigenic peptide , 2001, The EMBO journal.

[51]  Bjoern Peters,et al.  Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.

[52]  Bjoern Peters,et al.  Identifying MHC Class I Epitopes by Predicting the TAP Transport Efficiency of Epitope Precursors , 2003, The Journal of Immunology.

[53]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[54]  S. Mahalingam,et al.  Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. , 1995, Virology.

[55]  Alessandro Sette,et al.  Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method , 2005, BMC Bioinformatics.

[56]  P. Kloetzel,et al.  Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding , 2005, Cellular and Molecular Life Sciences CMLS.

[57]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[58]  Peter V. Coveney,et al.  The Role of Multiscale Protein Dynamics in Antigen Presentation and T Lymphocyte Recognition , 2017, Front. Immunol..

[59]  John Yin,et al.  Robust growth of human immunodeficiency virus type 1 (HIV-1). , 2005, Biophysical journal.

[60]  L. Lai,et al.  Modeling the intracellular dynamics for Vif-APO mediated HIV-1 virus infection , 2010 .

[61]  E. Rosenberg,et al.  The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Jonathan W. Arthur,et al.  Predicting Peptide Binding Affinities to MHC Molecules Using a Modified Semi-Empirical Scoring Function , 2011, PloS one.

[63]  Marc C. Johnson,et al.  The stoichiometry of Gag protein in HIV-1 , 2004, Nature Structural &Molecular Biology.

[64]  M. Delbrück,et al.  THE GROWTH OF BACTERIOPHAGE , 1939, The Journal of general physiology.